STOCK TITAN

Tevogen (TVGNW) SEC Filings, Jun-Jul 2025

TVGNW NASDAQ
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.28%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.43%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

The SEC has declared Tevogen Bio Holdings' Form S-3 registration statement effective as of June 26, 2025, at 4:30 P.M. This Form S-3 filing (File Number: 333-288218) represents a shelf registration statement that allows the company to offer and sell securities to the public.

Form S-3 is a simplified security registration form used by companies that have met certain reporting requirements and have a minimum public float. This effectiveness notice indicates that:

  • Tevogen Bio Holdings can now proceed with its planned securities offering
  • The company has satisfied SEC registration requirements
  • The registration statement has been reviewed and approved by the SEC

This development is significant for investors as it enables Tevogen Bio Holdings to access the capital markets more efficiently, potentially leading to future securities offerings under this shelf registration.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

How many Tevogen (TVGNW) SEC filings are available on StockTitan?

StockTitan tracks 53 SEC filings for Tevogen (TVGNW), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Tevogen (TVGNW)?

The most recent SEC filing for Tevogen (TVGNW) was filed on July 10, 2025.